These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9108071)

  • 21. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
    Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
    J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.
    Veitch NJ; Ennis M; McAbney JP; ; Shelbourne PF; Monckton DG
    DNA Repair (Amst); 2007 Jun; 6(6):789-96. PubMed ID: 17293170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of potential interactive genetic factors in Huntington's disease.
    Panegyres PK; Beilby J; Bulsara M; Toufexis K; Wong C
    Eur Neurol; 2006; 55(4):189-92. PubMed ID: 16772714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds.
    Gayán J; Brocklebank D; Andresen JM; Alkorta-Aranburu G; ; Zameel Cader M; Roberts SA; Cherny SS; Wexler NS; Cardon LR; Housman DE
    Genet Epidemiol; 2008 Jul; 32(5):445-53. PubMed ID: 18481795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Huntington disease.
    Kay C; Hayden MR; Leavitt BR
    Handb Clin Neurol; 2017; 144():31-46. PubMed ID: 28947124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.
    Saft C; Andrich JE; Brune N; Gencik M; Kraus PH; Przuntek H; Epplen JT
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1692-6. PubMed ID: 15548484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis].
    Sánchez A; Milà M; Castellví-Bel S; Calopa M; Genís D; Jiménez D; Estivill X
    Med Clin (Barc); 1997 May; 108(18):687-90. PubMed ID: 9324583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of the GRIK2 modifier effect in Huntington's disease.
    Zeng W; Gillis T; Hakky M; Djoussé L; Myers RH; MacDonald ME; Gusella JF
    BMC Neurosci; 2006 Sep; 7():62. PubMed ID: 16959037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships of the 2642 deletion polymorphism (delta 2642) in the huntingtin gene with the CAG repeat expansion length and age at onset of the disease.
    Lucotte G; Gérard N; Roubertoux P; Schmitt I; Riess O
    Genet Couns; 1996; 7(4):297-302. PubMed ID: 8985734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.
    Li JL; Hayden MR; Almqvist EW; Brinkman RR; Durr A; Dodé C; Morrison PJ; Suchowersky O; Ross CA; Margolis RL; Rosenblatt A; Gómez-Tortosa E; Cabrero DM; Novelletto A; Frontali M; Nance M; Trent RJ; McCusker E; Jones R; Paulsen JS; Harrison M; Zanko A; Abramson RK; Russ AL; Knowlton B; Djoussé L; Mysore JS; Tariot S; Gusella MF; Wheeler VC; Atwood LD; Cupples LA; Saint-Hilaire M; Cha JH; Hersch SM; Koroshetz WJ; Gusella JF; MacDonald ME; Myers RH
    Am J Hum Genet; 2003 Sep; 73(3):682-7. PubMed ID: 12900792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
    Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
    BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms.
    Hećimović S; Klepac N; Vlasić J; Vojta A; Janko D; Skarpa-Prpić I; Canki-Klain N; Marković D; Bozikov J; Relja M; Pavelić K
    Hum Mutat; 2002 Sep; 20(3):233. PubMed ID: 12204002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective study of the impact of lifestyle on age at onset of Huntington disease.
    Trembath MK; Horton ZA; Tippett L; Hogg V; Collins VR; Churchyard A; Velakoulis D; Roxburgh R; Delatycki MB
    Mov Disord; 2010 Jul; 25(10):1444-50. PubMed ID: 20629137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.